TRML
Tourmaline Bio
TRML
TRML
Delisted
TRML was delisted on the 27th of October, 2025.
58 hedge funds and large institutions have $79.7M invested in Tourmaline Bio in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 11 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.27% less ownership
Funds ownership: 6.46% → 6.18% (-0.27%)
45% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 20
Holders
58
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.09M | |
| 2 | +$4.41M | |
| 3 | +$2.75M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.02M |
| 5 |
QF
QVT Financial
New York
|
+$1.79M |
Top Sellers
| 1 | -$6.18M | |
| 2 | -$3.14M | |
| 3 | -$2.93M | |
| 4 |
Citigroup
New York
|
-$2.53M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.53M |